Celerus Diagnostics to present Wave RPD totally automated HC staining system at annual USCAP meeting

NewsGuard 100/100 Score

Celerus Diagnostics will introduce a totally automated immunohistochemistry (IHC) staining system, the much-anticipated Wave RPD, at the United States and Canadian Association of Pathologists (USCAP) annual meeting being held in Washington DC, March 22–24. The new system is the first of its kind, capable of delivering totally automated IHC results in one hour.

“Pathologists will have the ability to see IHC results that can aid in a differential diagnosis faster than ever before”

"We're extremely proud to present the Wave RPD, our second generation Rapid IHC® system,” said CEO Dave Gross. “The Wave RPD System is unparalleled in the industry and this annual meeting of leading US and Canadian pathologists is the ideal venue for its introduction."

On-board heating technology and sophisticated thermal control software have been added to the Wave RPD System, allowing for rapid deparaffinization and antigen retrieval. These steps, along with the patented Wave motion technology, deliver Rapid IHC® results in one hour. This significantly improved turnaround time is one third of other IHC instruments taking up to three or more hours.

"Pathologists will have the ability to see IHC results that can aid in a differential diagnosis faster than ever before," said Jason Lusk, VP of Business Development. "For a patient waiting on laboratory tests, a possible cancer diagnosis and subsequent treatment options, this reduced turnaround time is significant. The Wave RPD System will deliver the fastest standardized, high-quality IHC results available."

The new capabilities of the Wave RPD System will drive future growth at Celerus beyond IHC and into rapid molecular assays. Feasibility has now been demonstrated for same-day fluorescent in situ hybridization (FISH) and same-day chromogenic in situ hybridization (CISH) of common DNA targets such as Her2/neu.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breathing New Life into Diagnostics: Plasmion's SICRIT® Technology